Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Afr Health Sci ; 18(3): 767-775, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30603010

ABSTRACT

BACKGROUND: The use of illicit drugs has become a worldwide health problem. Substances with the potential to be abused may have direct or indirect effects on physiologic mechanisms that lead to organ system dysfunction and diseases. OBJECTIVE: The present study aims to investigate the structural and reabsorption integrity of the nephron among Egyptian addicts of tramadol alone and coabused with cannabis. METHODS: Sixty-five males were included in the study, they were classified into control group (G1=19), tramadol addicts group (G2=18), and tramadol coabused with cannabis addicts group (G3=28). Parameters investigated for structural integrity were urinary levels ofleucineaminopeptidase and N-acetyl-ß-D-glucosaminidase, and urinary parameters for reabsorption integrity were levels of copper and zinc as well as calcium, also urinary creatinine was measured. In addition, urinary levels of tramadol and tetrahydrocannabinol were estimated. RESULTS: Among the two addicted groups, all measured parameters were not significantly different in comparison with the control group except for urinary calcium excretion which was found to be significantly increased among the two addicted groups. CONCLUSION: Both tramadol addiction alone or coabused with cannabis causes increased urinary excretion of calcium, indicating reabsorption dysfunction of calcium without affecting structural integrity along the nephron.


Subject(s)
Calcium/urine , Copper/urine , Marijuana Abuse/complications , Opioid-Related Disorders/complications , Tramadol , Zinc/urine , Adult , Case-Control Studies , Creatinine/urine , Cross-Sectional Studies , Egypt/epidemiology , Humans , Male , Marijuana Abuse/epidemiology , Marijuana Abuse/urine , Opioid-Related Disorders/epidemiology , Opioid-Related Disorders/urine , Young Adult
3.
Pediatr Nephrol ; 30(10): 1835-42, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25980471

ABSTRACT

BACKGROUND: Iron deficiency anemia (IDA) is the most common nutritional deficiency in the world. The aim of our study was to evaluate and compare renal functional and structural integrity in 50 infants with IDA and 50 healthy controls and to assess the relation between IDA and oxidative stress and response to iron therapy. METHODS: This was a prospective study in which peripheral blood samples were collected from all study subjects and the following laboratory investigations performed: serum iron profile, urinary microalbumin, urinary leucine aminopeptidase (LAP), fractional excretion of sodium (FeNa), serum total antioxidant capacity (TAC), serum malondialdehyde (MDA), serum and urinary trace elements (iron, copper, zinc, calcium and magnesium). All patients received oral iron therapy and were followed-up for 3 months. RESULTS: The levels of baseline urinary markers were higher among the patients with IDA than among the controls (p < 0.05). Patients had a lower pre-therapy TAC and lower serum zinc and magnesium levels than controls as well as higher MDA and serum copper levels (p < 0.05). MDA level was positively correlated to microalbumin and LAP level (p < 0.05). Urinary LAP concentration was positively correlated to urinary trace element concentrations (p < 0.05). A significant decrease in microalbumin, LAP, FeNa, and urinary trace elements was observed post-iron therapy while hemoglobin and ferritin levels were increased (p < 0.05). CONCLUSION: Among the study subjects, IDA had an adverse influence on renal functional and structural integrity which could be reversed with iron therapy. Oxidative stress played an important role in the pathogenesis of renal injury in IDA.


Subject(s)
Anemia, Iron-Deficiency/physiopathology , Glomerular Filtration Rate/physiology , Iron Compounds/therapeutic use , Iron/blood , Kidney/physiopathology , Oxidative Stress , Renal Insufficiency/prevention & control , Administration, Oral , Anemia, Iron-Deficiency/drug therapy , Anemia, Iron-Deficiency/metabolism , Biomarkers/blood , Biomarkers/urine , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Iron Compounds/administration & dosage , Male , Prospective Studies , Reactive Oxygen Species/metabolism , Renal Insufficiency/etiology , Renal Insufficiency/physiopathology , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...